[
  {
    "ts": null,
    "headline": "Bristol Myers Stock: This Covered Call Could Enhance Your Return Beyond A 4% Dividend Yield",
    "summary": "Bristol Myers Squibb has been a strong performer in the six months, rising over 23% in that time.  Investors desiring to increase income from Bristol Myers stock could look at selling covered calls on their underlying stock position to increase their income.  Bristol Myers stock, despite falling Monday, also trades above both the 50- and 200-day moving averages.",
    "url": "https://finnhub.io/api/news?id=1805ee6cecb71ce0973dcfc593cc04389eff2386173ed452a8eb5fb779f1aae7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742836499,
      "headline": "Bristol Myers Stock: This Covered Call Could Enhance Your Return Beyond A 4% Dividend Yield",
      "id": 133360453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers Squibb has been a strong performer in the six months, rising over 23% in that time.  Investors desiring to increase income from Bristol Myers stock could look at selling covered calls on their underlying stock position to increase their income.  Bristol Myers stock, despite falling Monday, also trades above both the 50- and 200-day moving averages.",
      "url": "https://finnhub.io/api/news?id=1805ee6cecb71ce0973dcfc593cc04389eff2386173ed452a8eb5fb779f1aae7"
    }
  },
  {
    "ts": null,
    "headline": "Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?",
    "summary": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 in […]",
    "url": "https://finnhub.io/api/news?id=20b3cd532c436ed56da05795e139fa8d1d5f0bd0a31f4d46beef8973f7c007c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742821749,
      "headline": "Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?",
      "id": 133337987,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 in […]",
      "url": "https://finnhub.io/api/news?id=20b3cd532c436ed56da05795e139fa8d1d5f0bd0a31f4d46beef8973f7c007c0"
    }
  },
  {
    "ts": null,
    "headline": "Chipotle and 8 More Growth Stocks Could Beat Tech in a Volatile Market",
    "summary": "Chipotle and 8 More Growth Stocks Could Beat Tech in a Volatile Market",
    "url": "https://finnhub.io/api/news?id=f9b8af169a7582bcc314df0fd8b950f2d003e70f82c286e23d65bc854e81971b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742820060,
      "headline": "Chipotle and 8 More Growth Stocks Could Beat Tech in a Volatile Market",
      "id": 134150148,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Chipotle and 8 More Growth Stocks Could Beat Tech in a Volatile Market",
      "url": "https://finnhub.io/api/news?id=f9b8af169a7582bcc314df0fd8b950f2d003e70f82c286e23d65bc854e81971b"
    }
  },
  {
    "ts": null,
    "headline": "8 key drug patents expiring soon — and what it means for the market",
    "summary": "Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor enters the market. With four generic competitors, prices tumble by 79%. These reductions translate into billions of dollars in savings for American consumers.",
    "url": "https://finnhub.io/api/news?id=3f04cb1a714d7367e3396e8a63ab1fd68b8221fd00b5286b9e4292230b189bfa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742806800,
      "headline": "8 key drug patents expiring soon — and what it means for the market",
      "id": 133337988,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor enters the market. With four generic competitors, prices tumble by 79%. These reductions translate into billions of dollars in savings for American consumers.",
      "url": "https://finnhub.io/api/news?id=3f04cb1a714d7367e3396e8a63ab1fd68b8221fd00b5286b9e4292230b189bfa"
    }
  }
]